Please disable your adblock and script blockers to view this page

Covid-19 Vaccine Front-Runners Impress Investors, but Concerns Exist


MembershipCustomer ServiceTools & FeaturesAdsMoreDow Jones Products

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

No matching tags

Positivity     14.00%   
   Negativity   86.00%
The New York Times
SOURCE: https://www.wsj.com/articles/covid-19-vaccine-front-runners-impress-investors-but-concerns-exist-11596533401?mod=hp_lead_pos2
Write a review: The Wall Street Journal
Summary

Gene-based vaccines from Moderna, Pfizer and its partner BioNTech are drawing early enthusiasm, but investors are hesitant to up stakes because valuations have soared

As said here by Gregory Zuckerman, Joseph Walker